Physician profile
Jodi E Gustave
NPI 1174554190
$507.12
in general payments reported to CMS, 2019-2025
12 companies · $193 in 2025
The $193 reported for 2025 was more than what a typical Pediatric Pulmonology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2021: $44.60 · 2022: $47.06 · 2023: $16.30 · 2024: $41.56 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $250.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $141.81 | 2025 | |
| Philips North America LLC | $119.53 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $76.03 | 2019 | |
| Corium, LLC | $32.87 | 2023-2025 | Azstarys |
| Regeneron Healthcare Solutions, INC. | $29.79 | 2019 | |
| Collegium Pharmaceutical, INC. | $18.15 | 2025 | Jornay Pm |
| Phadia US INC. | $16.74 | 2021 | |
| Avadel Cns Pharmaceuticals, LLC | $15.97 | 2025 | Lumryz |
| Aucta Pharmaceuticals, INC. | $15.34 | 2024 | Motpoly Xr |
| Kaleo, INC. | $14.67 | 2019 | |
| Ironshore Pharmaceuticals INC. | $13.14 | 2024 | |
| Tris Pharma INC | $13.08 | 2024 | Dyanavel Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jodi Gustave listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.